EGLARO S 5/100MG TAB

EGLARO S 5/100MG TAB contains Ertugliflozin 5mg and Sitagliptin 100mg, a dual-action combination designed to help manage type 2 diabetes. Ertugliflozin works by increasing glucose excretion through urine, while Sitagliptin enhances insulin secretion and reduces glucagon levels. This synergistic approach helps improve blood sugar control in patients inadequately managed on monotherapy. Suitable for adult diabetic patients requiring combination therapy for optimal glycemic management.